ETF Holdings Breakdown of RCKT

Stock NameRocket Pharmaceuticals Inc
TickerRCKT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS77313F1066
LEI549300R7VV82YUIN4Y93

News associated with RCKT

Mariner LLC Takes Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Mariner LLC bought a new position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,061 shares of the biotechnology company’s stock, valued at approximately $139,000. Other institutional investors […] - 2025-05-09 07:36:56
Analysts Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) PT at $43.00
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twelve research firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 1 […] - 2025-05-06 06:07:08
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Bought by Legal & General Group Plc
Legal & General Group Plc raised its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 3.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 75,454 shares of the biotechnology company’s stock after purchasing an additional 2,416 shares during the quarter. […] - 2025-04-28 07:56:54
Raymond James Financial Inc. Acquires Shares of 22,645 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Raymond James Financial Inc. acquired a new position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 22,645 shares of the biotechnology company’s stock, valued at approximately $285,000. Other hedge funds and other institutional investors have also made changes to their positions in the […] - 2025-04-11 07:56:49
Mitsubishi UFJ Asset Management Co. Ltd. Has $254,000 Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 68.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,196 shares of the biotechnology company’s stock after buying an additional 8,190 […] - 2025-04-04 08:12:55
Blair William & Co. IL Reduces Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Blair William & Co. IL reduced its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 14.0% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 116,038 shares of the biotechnology company’s stock after selling 18,931 shares during the quarter. Blair William & Co. IL’s holdings in Rocket Pharmaceuticals were worth […] - 2025-04-03 08:27:07
Teacher Retirement System of Texas Purchases 7,211 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Teacher Retirement System of Texas raised its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 45.2% during the 4th quarter, Holdings Channel reports. The fund owned 23,148 shares of the biotechnology company’s stock after purchasing an additional 7,211 shares during the period. Teacher Retirement System of Texas’ holdings in Rocket Pharmaceuticals […] - 2025-04-02 07:42:48
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Bought by Signaturefd LLC
Signaturefd LLC grew its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 319.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,916 shares of the biotechnology company’s stock after buying an additional 3,745 shares during the quarter. Signaturefd LLC’s holdings […] - 2025-03-25 08:03:00
Harbour Investments Inc. Acquires 1,840 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Harbour Investments Inc. lifted its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 51.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 5,385 shares of the biotechnology company’s stock after acquiring an additional 1,840 shares during the period. Harbour Investments Inc.’s holdings in Rocket Pharmaceuticals were worth $68,000 as of […] - 2025-03-24 08:02:55
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. The […] - 2025-03-14 07:12:56
Canaccord Genuity Group Has Lowered Expectations for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its price target lowered by research analysts at Canaccord Genuity Group from $39.00 to $36.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 315.70% […] - 2025-03-05 10:08:58
Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 1-Year Low on Analyst Downgrade
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) shares reached a new 52-week low on Monday after The Goldman Sachs Group lowered their price target on the stock from $29.00 to $15.00. The Goldman Sachs Group currently has a neutral rating on the stock. Rocket Pharmaceuticals traded as low as $8.93 and last traded at […] - 2025-03-04 06:56:43
Rocket Pharmaceuticals (NASDAQ:RCKT) Given New $54.00 Price Target at Chardan Capital
Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) had its target price decreased by Chardan Capital from $62.00 to $54.00 in a research report report published on Friday morning,Benzinga reports. Chardan Capital currently has a buy rating on the biotechnology company’s stock. Other research analysts have also issued reports about the stock. Cantor Fitzgerald reissued an “overweight” […] - 2025-03-03 06:48:48
Strategic Financial Concepts LLC Makes New Investment in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Strategic Financial Concepts LLC bought a new stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 11,250 shares of the biotechnology company’s stock, valued at approximately $141,000. A number of other institutional investors and hedge funds also recently made changes to their positions in the […] - 2025-02-13 09:05:07
Jennison Associates LLC Raises Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Jennison Associates LLC lifted its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 72.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 70,304 shares of the biotechnology company’s stock after acquiring an additional 29,564 shares during the quarter. […] - 2025-02-07 09:59:00

RCKT institutional holdings

The following institutional investment holdings of RCKT have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 52,504USD 369,628
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 154,490USD 1,087,610
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 49,928USD 351,493
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 49,928USD 351,493 4.8%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 3,684USD 25,935
Total =310,534 USD 2,186,159
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.